Sterile signals generate weaker and delayed macrophage NLRP3 inflammasome responses relative to microbial signals

por Bezbradica, Jelena S, Coll, Rebecca C, Schroder, Kate
Publicado 2017

The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes

por Coll, Rebecca C., O'Neill, Luke A. J.
Publicado 2011

Correction: The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes

por Coll, Rebecca C., O'Neill, Luke A. J.
Publicado 2013

Correction: The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes

por Coll, Rebecca C., O'Neill, Luke A. J.
Publicado 2013

PHOrming the inflammasome: phosphorylation is a critical switch in inflammasome signalling

por McKee, Chloe M., Fischer, Fabian A., Bezbradica, Jelena S., Coll, Rebecca C.
Publicado 2021

The Achromobacter type 3 secretion system drives pyroptosis and immunopathology via independent activation of NLRC4 and NLRP3 inflammasomes

por Turton, Keren, Parks, Hannah J., Zarodkiewicz, Paulina, Hamad, Mohamad A., Dwane, Rachel, Parau, Georgiana, Ingram, Rebecca J., Coll, Rebecca C., Bryant, Clare E., Valvano, Miguel A.
Publicado 2023

Caspase-1 self-cleavage is an intrinsic mechanism to terminate inflammasome activity

por Boucher, Dave, Monteleone, Mercedes, Coll, Rebecca C., Chen, Kaiwen W., Ross, Connie M., Teo, Jessica L., Gomez, Guillermo A., Holley, Caroline L., Bierschenk, Damien, Stacey, Katryn J., Yap, Alpha S., Bezbradica, Jelena S., Schroder, Kate
Publicado 2018

Interleukin-10 regulates the inflammasome-driven augmentation of inflammatory arthritis and joint destruction

por Greenhill, Claire J, Jones, Gareth W, Nowell, Mari A, Newton, Zarabeth, Harvey, Ann K, Moideen, Abdul N, Collins, Fraser L, Bloom, Anja C, Coll, Rebecca C, Robertson, Avril AB, Cooper, Matthew A, Rosas, Marcela, Taylor, Philip R, O’Neill, Luke A, Humphreys, Ian R, Williams, Anwen S, Jones, Simon A
Publicado 2014